Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Video Expert Opinion
Colleague Insights
Conferences
Sign in
Join now
Marinos Dalakas MD, FAAN
Marinos C. Dalakas MD, FAAN Advisory Board
Mark Hallett MD
Mark Hallett MD Editor-in-Chief
Argye Hillis MD, MA
Argye Elizabeth Hillis MD, MA Associate Editor
See All Experts
Published in Neurology and
1 other channel

Journal Scan / Research · July 24, 2023

Safety of Live Attenuated Varicella-Zoster Virus Vaccination in Patients With Relapsing–Remitting MS Treated With Natalizumab

Multiple Sclerosis and Related Disorders

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Ahmed Obeidat MD, PhD

Multiple Sclerosis and Related Disorders
Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literature
Mult Scler Relat Disord 2023 Sep 01;77(xx)104793, S Paybast, MA Sahraian, MA Nahayati, MA Habibi, S Shahmohammadi, S Navardi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated